Kringle Pharma, Inc. had a revenue of 17.77M in the quarter ending Mar 31, 2025, with -2.17%. This bring the company's revenue in the last twelve months to 72.90M, Increased -8.27%. In the fiscal year ending Dec 31, 2024, Kringle Pharma, Inc. had annual revenue of 80.04M with 15.58% growth.